Jonathan Allan

GENERAL COUNSEL & CORP SEC

Jonathan Allan (GENERAL COUNSEL & CORP SEC) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Stoke Therapeutics, Inc. (STOK). The largest single filing was $292K of STOK (8,692 sh × $33.64, as filed), executed Mar 20.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 4 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$844K

shares × price, as filed

Last traded

Mar 20

Filed Mar 24

Median ADV $25.8M across their filed names

Open performance→

Volume by month

Buys $0 Sells $1.8M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 4 filings

Sector per market data · by filing · past 12 months

Most traded names

STOK

Stoke Therapeutics, Inc. STOK · 0 buys · 8 sells 8 filings

Recent filings

STOKSALE Stoke Therapeutics, Inc. View filing → $292K
8,692 sh × $33.64
Exec Mar 20
Filed Mar 24 · 5:30 PM ET STOKSALE Stoke Therapeutics, Inc. View filing → $132K
4,222 sh × $31.28
Exec Mar 18
Filed Mar 19 · 5:30 PM ET STOKSALE Stoke Therapeutics, Inc. View filing → $169K
5,437 sh × $31.08
Exec Dec 5 2025
Filed Dec 5 2025 · 5:30 PM ET STOKSALE Stoke Therapeutics, Inc. View filing → $251K
10,000 sh × $25.07
Exec Oct 3 2025
Filed Oct 7 2025 · 5:30 PM ET STOKSALE Stoke Therapeutics, Inc. View filing → $428K
21,267 sh across 2 lots
Exec Sep 2 2025
Filed Sep 3 2025 · 5:30 PM ET STOKSALE Stoke Therapeutics, Inc. View filing → $206K
13,712 sh × $15.00
Exec Aug 13 2025
Filed Aug 15 2025 · 5:30 PM ET STOKSALE Stoke Therapeutics, Inc. View filing → $166K
12,114 sh × $13.69
Exec Dec 9 2024
Filed Dec 11 2024 · 5:30 PM ET STOKSALE Stoke Therapeutics, Inc. View filing → $124K
9,696 sh × $12.78
Exec Dec 6 2024
Filed Dec 10 2024 · 5:30 PM ET